Antibody therapy in renal cell carcinoma

The treatment of metastasized renal cell carcinoma (RCC) still represents a formidable challenge, despite the development of small molecule, tyrosine kinase inhibitors (TKI) that have made a major impact on the disease. Although the percentage of patients achieving a partial response or stabilizatio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Oosterwijk, Egbert, Boerman, Otto C., Oyen, Wim J. C., Old, Lloyd J., Mulders, Peter F. A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2008
Gaiak:
Topic Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2295251/
https://ncbi.nlm.nih.gov/pubmed/18239922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00345-008-0236-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak